Heart Disease Prevention and Coronary Care: Evidence and Safety Guide

Key takeaways WHO reports cardiovascular disease caused an estimated 19.8 million deaths in 2022 — about 32% of all global deaths — with heart attack and stroke accounting for 85% of that toll (WHO CVD fact sheet). In PREDIMED’s reanalysis, a Mediterranean eating pattern plus olive oil or nuts reduced the combined cardiovascular-event endpoint in … Read more

Cancer Supplements and Food Claims: Evidence and Safety

Key takeaways The strongest ingredient-level evidence is for food, not pills: a dose-response meta-analysis found every 10 g/day increase in dietary fiber was associated with a 10% lower colorectal cancer risk (RR 0.90), and three daily servings of whole grains were linked to a 17% lower risk (RR 0.83). A WHO-commissioned review included 47 trials … Read more

Cancer Prevention and Supportive Care: Evidence and Safety Guide

Key takeaways WHO states about 38% of cancers can currently be prevented by avoiding known risk factors and applying evidence-based prevention strategies — meaningful risk reduction, not a guarantee (WHO cancer fact sheet). IARC classifies alcoholic beverages and processed meat as carcinogenic to humans, and red meat as probably carcinogenic. Alcohol causes cancers at several … Read more

CoQ10: Ubiquinone vs Ubiquinol, Heart Health, and Statin Muscle Pain

Key takeaways Statin-associated muscle pain evidence is mixed. Qu 2018 included 12 trials (575 participants), with nine trials (433 participants) contributing to the pain analysis; it did not establish a universal 30% reduction. Kennedy 2020 found no significant pain benefit. The 2025 meta-analysis was positive overall, but highly heterogeneous and sensitive to which studies were … Read more

Omega-3: Fish Oil, Krill, Algal — Which Form Actually Works

Key takeaways Strongest evidence: modest triglyceride reduction (around 20–30% with 4 g/day prescription omega-3 in people with elevated triglycerides) and reduced cardiovascular events in secondary prevention at prescription doses — FDA has approved icosapent ethyl (EPA-only, 4 g) after the REDUCE-IT trial. (Primary source) For primary prevention of heart disease in the general population, effects … Read more

One daily research roundup

Get the topics, key findings and links from our new articles in one email. At most one digest a day, only when there is something new.

Confirm through your inbox. Unsubscribe anytime. Research only; Shop updates have a separate signup. Please do not send health information.